Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

For this reason, the CDC recommends adults 50 or older schedule the following vaccines, which many people can get for free.

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...

The Affordable Care Act requires all insurance companies to cover, for free, all vaccines the panel recommends. Those ...

RFK dismissed the CDC's scientific vaccine advisers. His appointees for replacements are raising concerns about vaccine ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

Moderna Falls on Doubts Over New CDC Panel's Backing of RSV Vaccine By Mariam Sunny (Reuters) -Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back ...

(Reuters) -Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader ...